Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PPD - PPD Inc


Close
47.28
-0.030   -0.063%

Share volume: 0
Last Updated: Tue 07 Dec 2021 10:00:00 PM CET
Testing Laboratories: -3.17%

PREVIOUS CLOSE
CHG
CHG%

$47.31
-0.03
-0.06%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
73%
Profitability 75%
Dept financing 50%
Liquidity 75%
Performance 75%
Company vs Stock growth
vs
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$47.28
P/E Ratio 
0.00
DAY RANGE
$47.24 - $47.40
EPS 
$1.00
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
16.614 B
YIELD 
N/A
SHARES OUTSTANDING 
351.395 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO:
Region: US
Website: www.ppdi.com
Employees: 24,000
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Testing Laboratories
Sector: Professional, Scientific, and Technical Services

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Company's customers include pharmaceutical, biotechnology, medical device, academic and government organization s. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.

Recent news